SAT0465 An integrated safety data analysis across all phase ii and phase iii clinical programs for ustekinumab in psoriatic arthritis, crohn's disease, and psoriasis. Annals of the rheumatic diseases 2017 https://researcherprofiles.org/profile/79292866 LS Gensler, E Hsia, C Gasink, B Randazzo, D Parenti, S Fakharzadeh, L-L Gao, SD Chakravarty
